Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX1 | P51575 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 4/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | SIRT2 | Q8IXJ6 | 4/20 | 0.59 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.59 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.51 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | GRM5 | P41594 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL384593 | 0.86 | FABP4 (0.65) | P2RX1ALDH1A1HTTSIRT2NPC1 | |
| SCHEMBL338230 | 0.82 | HSPD1 (0.57) | P2RX1ALDH1A1HTTMEN1KMT2A | |
| SCHEMBL16676676 | 0.81 | RAB9A (0.76) | P2RX1ALDH1A1HTTMEN1KMT2A | |
| SCHEMBL7820408 | 0.80 | P2RX1 (0.72) | P2RX1ALDH1A1HTTMEN1KMT2A | |
| SCHEMBL2301076 | 0.80 | PARP1 (0.65) | P2RX1ALDH1A1HTTMEN1KMT2A | |
| SCHEMBL28660772 | 0.79 | MAPT (0.69) | P2RX1ALDH1A1MEN1KMT2ASIRT2 | |
| SCHEMBL9611892 | 0.79 | MEN1 (0.57) | ALDH1A1HTTMEN1KMT2ASIRT2 | |
| SCHEMBL14339391 | 0.77 | EGFR (0.54) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL2700843 | 0.77 | P2RX1 (1.00) | P2RX1ALDH1A1HTTMEN1KMT2A | |
| SCHEMBL3237318 | 0.77 | MEN1 (0.75) | ALDH1A1HTTMEN1KMT2ASIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2174932-B1 | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same | IDEMITSU KOSAN CO (JP) | 2019-07-03 | — | — | EP | disclosed |
| EP-2174933-B1 | BENZIMIDAZOLE DERIVATIVES FOR USE IN ORGANIC ELECTROLUMINESCENT DEVICES | IDEMITSU KOSAN CO (JP) | 2019-04-03 | — | — | EP | disclosed |
| US-8097349-B2 | Nitrogen containing heterocycle derivative and organic electroluminescent element using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2012-01-17 | — | — | US | disclosed |
| US-7851071-B2 | 2-[4-(10-naphthalene-2-yl-anthracene-9-yl)-phenyl]-1-phenyl-1H-benzimidazole; elevation of luminance and of efficiency in light emission even under low driving voltage | IDEMITSU KOSAN CO., LTD. (JP) | 2010-12-14 | — | — | US | disclosed |
| US-20100193773-A1 | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same | IDEMITSU KOSAN CO., LTD, (JP) | 2010-08-05 | — | — | US | disclosed |
| EP-2174932-A2 | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same | Idemitsu Kosan Co., Ltd. (JP) | 2010-04-14 | — | — | EP | disclosed |
| EP-2174933-A2 | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same | Idemitsu Kosan Co., Ltd. (JP) | 2010-04-14 | — | — | EP | disclosed |
| US-20060147747-A1 | 2-[4-(10-naphthalene-2-yl-anthracene-9-yl)-phenyl]-1-phenyl-1H-benzimidazole; elevation of luminance and of efficiency in light emission even under low driving voltage | IDEMITSU KOSAN CO., LTD. (JP) | 2006-07-06 | — | — | US | disclosed |
| EP-1602648-A1 | NITROGEN-CONTAINING HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2005-12-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100193773-A1 | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same | NSD1, EED, ERG | P2RX1 2123/4885ALDH1A1 1048/4885HTT 2304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.